Cargando…

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity

Detalles Bibliográficos
Autores principales:	Jacinto, Jorge, Varriale, Pasquale, Pain, Emilie, Lysandropoulos, Andreas, Esquenazi, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774334/ https://www.ncbi.nlm.nih.gov/pubmed/33391178 http://dx.doi.org/10.3389/fneur.2020.629181

Ejemplares similares

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study
por: Jacinto, Jorge, et al.
Publicado: (2022)

A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: Anatomy, physiology, and goal setting
por: Jacinto, Jorge, et al.
Publicado: (2022)

A practical guide to botulinum neurotoxin treatment of shoulder spasticity 2: Injection techniques, outcome measurement scales, and case studies
por: Wissel, Jörg, et al.
Publicado: (2022)

Botulinum Neurotoxin-A Injection in Adult Cervical Dystonia and Spastic Paresis: Results From the INPUT (INjection Practice, Usage and Training) Survey
por: Chung, Tae Mo, et al.
Publicado: (2020)

Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2020)

Correction to: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2020)

Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies
por: Esquenazi, Alberto, et al.
Publicado: (2020)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020)

Corrections required for Dressler and Johnson 2022
por: Esquenazi, Alberto, et al.
Publicado: (2022)

LONGITUDINAL GOAL ATTAINMENT WITH INTEGRATED UPPER LIMB SPASTICITY MANAGEMENT INCLUDING REPEAT INJECTIONS OF BOTULINUM TOXIN A: FINDINGS FROM THE PROSPECTIVE, OBSERVATIONAL UPPER LIMB INTERNATIONAL SPASTICITY (ULIS-III) COHORT STUDY
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)

CLINICAL PRESENTATION OF PATIENTS WITH LOWER LIMB SPASTICITY UNDER-GOING ROUTINE TREATMENT WITH BOTULINUM TOXIN: BASELINE FINDINGS FROM AN INTERNATIONAL OBSERVATIONAL STUDY
por: ESQUENAZI, Alberto, et al.
Publicado: (2023)

Botulinum neurotoxin formulations: overcoming the confusion [Corrigendum]
Publicado: (2018)

Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective
por: Li, Yang, et al.
Publicado: (2021)

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)
por: Turner-Stokes, Lynne, et al.
Publicado: (2016)

The Expanding Therapeutic Utility of Botulinum Neurotoxins
por: Fonfria, Elena, et al.
Publicado: (2018)

Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study
por: Patel, Atul T, et al.
Publicado: (2020)

Therapeutic Applications of Botulinum Neurotoxins in Veterinary Medicine
por: Turin, Lauretta, et al.
Publicado: (2023)

Botulinum Neurotoxin Type A in Neurology: Update
por: Orsini, Marco, et al.
Publicado: (2015)

Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
por: Bar-On, Lynn, et al.
Publicado: (2020)

Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
por: Peck, Michael W., et al.
Publicado: (2017)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion
por: Lagnau, Philippe, et al.
Publicado: (2021)

Changes in Cortical Activity in Stroke Survivors Undergoing Botulinum Neurotoxin Therapy for Treatment of Focal Spasticity
por: Vinehout, Kaleb, et al.
Publicado: (2021)

Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb
por: Veverka, Tomáš, et al.
Publicado: (2019)

Characteristic Variation of Electromechanical Delay After the Botulinum Toxin Injection in Spastic Biceps Brachii Muscles
por: Chandra, Sourav, et al.
Publicado: (2022)

Joint and Muscle Assessments of the Separate Effects of Botulinum NeuroToxin-A and Lower-Leg Casting in Children With Cerebral Palsy
por: Peeters, Nicky, et al.
Publicado: (2020)

Botulinum Neurotoxins and Botulism: A Novel Therapeutic Approach
por: Thanongsaksrikul, Jeeraphong, et al.
Publicado: (2011)

Therapeutic applications of botulinum neurotoxins in head and neck disorders
por: Alshadwi, Ahmad, et al.
Publicado: (2014)

Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
por: Martina, Emanuela, et al.
Publicado: (2021)

Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France
por: Levy, Jonathan, et al.
Publicado: (2023)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy
por: Peeters, Nicky, et al.
Publicado: (2022)

Intramuscular Neural Distribution of Adductor Pollicis Muscle Spasticity in Cadaver Model Regarding Botulinum Neurotoxin Treatment
por: Yi, Kyu-Ho, et al.
Publicado: (2023)

THE SPASTICITY-RELATED QUALITY OF LIFE 6-DIMENSIONS INSTRUMENT IN UPPER-LIMB SPASTICITY: PART I DEVELOPMENT AND RESPONSIVENESS
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vcj90tft6323cbi0f4nv9j2212